Event
Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19
presented by Fox Chase Cancer Center
Event info
Click HERE to register.
The COVID-19 pandemic has precipitated many changes in medical practice. Join us for this virtual CME, where the Fox Chase Cancer Center genitourinary (GU) oncology team will discuss the impact of the pandemic on GU cancer care as well as the latest advances and treatments for GU malignancies.
Topics and Presenters
The faculty includes nationally recognized urologic, radiation and medical oncologists. They are prominent leaders and committee members in organizations, such as NCCN, AJCC and AUA. These clinicians are instrumental in writing national guidelines for GU cancer care. Drs. Kutikov and Geynisman are also contributing editors of the COVID-19 resources section of UpToDate®.
- COVID-19 and Cancer | Alexander Kutikov, MD, FACS
Chief, Division of Urology and Urologic Oncology Professor, Department of Surgical Oncology - Update on Metastatic Renal Cell Carcinoma | Matthew R. Zibelman, MD
Assistant Professor, Department of Hematology/Oncology - Update on Metastatic Urothelial Carcinoma | Pooja Ghatalia, MD
Assistant Professor, Department of Hematology/Oncology - Update on Metastatic Prostate Cancer | Fern M. Anari, MD
Assistant Professor, Department of Hematology/Oncology - Adjuvant vs. Salvage Radiation Therapy for Prostate Cancer: New Data | Jessica Karen Wong, MD, MEng
Assistant Professor, Department of Radiation Oncology Assistant Director, Radiation Oncology Residency and Fellowship Training Program - Updates on Surgery for Bladder, Kidney and Prostate Cancer | Rosalia Viterbo, MD, FACS
Associate Professor, Department of Surgical Oncology - Panel Discussion and Q&A | Moderated by Daniel M. Geynisman, MD
Associate Professor, Department of Hematology/Oncology
Intended Audience
The program is designed for medical, surgical and radiation oncologists, urologists, primary care physicians, fellows, residents and other healthcare providers.
Designation Statement
The Temple Health Office for Continuing Medical Education Designates This Live Activity for A Maximum of 1.5 AMA PRA Category 1 Credits™.
Course Syllabus
Click HERE to view the syllabus